(Q44564436)

4 December 2017

Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells (English)

1 reference

head and neck squamous cell carcinoma

4 December 2017

1 reference

Angela J Mantha

1

1 reference

4 December 2017

Kathryn E McFee

2

1 reference

4 December 2017

Nima Niknejad

3

1 reference

4 December 2017

Glenwood Goss

4

1 reference

4 December 2017

Ian A Lorimer

5

1 reference

4 December 2017

Jim Dimitroulakos

6

1 reference

4 December 2017

language of work or name

1 reference

26 August 2003

1 reference

Journal of Cancer Research and Clinical Oncology

4 December 2017

1 reference

4 December 2017

129

1 reference

4 December 2017

11

1 reference

4 December 2017

631-641

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-003-0490-2

4 December 2017

0 references

cites work

Regulation of the mevalonate pathway

1 reference

12 December 2020

Tyrosine kinase inhibitors-ZD1839 (Iressa).

1 reference

12 December 2020

Oxaliplatin: a review of preclinical and clinical studies.

1 reference

12 December 2020

The EGF receptor family as targets for cancer therapy

1 reference

12 December 2020

1 reference

12 December 2020

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

1 reference

12 December 2020

The Evaluation and Treatment of the Neck in Carcinoma of the Oral Cavity

1 reference

12 December 2020

Chemotherapy for recurrent and metastatic head and neck cancer

1 reference

12 December 2020

Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas

1 reference

12 December 2020

Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells

1 reference

12 December 2020

Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor c-terminal tail

1 reference

12 December 2020

Ras and Rho regulation of the cell cycle and oncogenesis

1 reference

12 December 2020

Cisplatin: from DNA damage to cancer chemotherapy.

1 reference

12 December 2020

The induction of P450-mediated oxidation of all-trans retinoic acid by retinoids in head and neck squamous cell carcinoma cell lines

1 reference

12 December 2020

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

1 reference

12 December 2020

Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.

1 reference

12 December 2020

CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck.

1 reference

12 December 2020

Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

1 reference

12 December 2020

Cancer statistics, 1992

1 reference

12 December 2020

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

1 reference

12 December 2020

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390)

1 reference

12 December 2020

Rab GTPases, intracellular traffic and disease.

1 reference

12 December 2020

Biosynthesis of the epidermal growth factor receptor: post-translational glycosylation-independent acquisition of tyrosine kinase autophosphorylation activity

1 reference

12 December 2020

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

1 reference

12 December 2020

5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development

1 reference

12 December 2020

Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells

1 reference

12 December 2020

The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets

1 reference

12 December 2020

EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells

1 reference

12 December 2020

Features of apoptotic cells measured by flow cytometry

1 reference

12 December 2020

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

1 reference

12 December 2020

1 reference

12 December 2020

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer

1 reference

12 December 2020

New platinum agents. A comparison in ovarian cancer

1 reference

12 December 2020

Role of conformational alteration in the epidermal growth factor receptor (EGFR) function

1 reference

12 December 2020

Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.

1 reference

12 December 2020

Cancer statistics, 1994.

1 reference

12 December 2020

Small GTP-binding proteins

1 reference

12 December 2020

Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin

1 reference

12 December 2020

Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism

1 reference

12 December 2020

Chemotherapy in the management of squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach

1 reference

12 December 2020

Apoptosis in cancer therapy: crossing the threshold

1 reference

12 December 2020

Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications

1 reference

12 December 2020

Pharmacology of competitive inhibitors of HMG-CoA reductase.

1 reference

12 December 2020

Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells

1 reference

12 December 2020

Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of action

1 reference

12 December 2020

Apoptosis modulators as cancer therapeutics.

1 reference

12 December 2020

Inhibition of epidermal-growth-factor-receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro

1 reference

12 December 2020

HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells

1 reference

12 December 2020

10.1007/S00432-003-0490-2

Identifiers

DOI

1 reference

4 December 2017

1 reference